Joel Greenblatt fit · Magic Formula - high ROIC + cheap EV/EBIT
Is Apellis Pharmaceuticals, Inc. (APLS) a Joel Greenblatt Stock?
Partial match - either cheap or high-quality, but not both.
63/100
CMixed signals
1/5 criteria passed
+8 sector-quality lift. Top-quintile within its sector on 4 of 5 quality metrics. Raw pillar score 55 → lifted to 63 before grade derivation.
Joel Greenblatt's Criteria, Applied to APLS
EBIT/EV yield ≥ 10%
key1.0%
ROIC ≥ 25%
key18.1%
EV/EBIT ≤ 12
96.0x
Gross margin ≥ 30%
90.1%
How APLS Scores on Other Strategies
Live Financial Snapshot
Market cap
$5.25B
P/E (TTM)
38.8x
ROIC (TTM)
18.11%
Gross margin
90.12%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is APLS's Joel Greenblatt fit score?
APLS scores 63/100 on our Joel Greenblatt fit engine - grade C. Partial match - either cheap or high-quality, but not both.
Does Joel Greenblatt actually own APLS?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends APLS.
How often is this score updated?
APLS's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends APLS.